What is Alzamend Neuro, Inc. (ALZN)?
Alzamend Neuro, Inc. is a biotechnology company focused on developing therapeutics for neurodegenerative diseases, including Alzheimer's disease and other cognitive disorders. The company employs a research-driven approach to identify and advance treatments that target underlying pathological mechanisms in the brain. Alzamend Neuro aims to address the unmet medical needs associated with neurodegeneration by developing novel drug candidates. Its research efforts encompass preclinical studies and clinical development phases. The company collaborates with scientific and medical communities to enhance its understanding of neurological conditions and to accelerate the development of effective therapies.
Alzamend Neuro, Inc. Stock Price Today: Live Overview
The price today is shaped by the ongoing price movements, with Alzamend Neuro, Inc. priced at $1.8654. The intraday low and high are $1.8146 and $2.1146 respectively, accompanied by a daily percentage change of -9.7819%.
FAQ: Alzamend Neuro, Inc. (ALZN)
What is the current price of ALZN stock?
Alzamend Neuro, Inc. shares are trading at $1.8654.
Does ALZN pay dividends?
Alzamend Neuro, Inc. does not currently pay dividends.
Does ALZN have a formal corporate presence or regional headquarters in the UAE?
Alzamend Neuro, Inc. operates in the UAE through partnerships without an official regional office or subsidiary.
What is ALZN best known for?
The company is most famous for its work in developing treatments for neurodegenerative diseases.
What assets are typically shown together with ALZN?
Commonly shown alongside ALZN: Vor Biopharma Inc., Dyadic International, Inc., Medpace Holdings Inc
Latest shares articles



